PT
Prometheus Therapeutics Inc.
SEC filingOther Health Care · Miramar, FL
Amount raised$2.7Msold at filing
Total offering$6.5M$3.8M still open
Investors in the raise13count reported to the SEC
FiledApr 15, 2026first sale Oct 28, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Alexander HastingsDirector
Bernie NavarroExecutive Officer
Baruch LieberExecutive Officer, Director
Ajay WakhlooExecutive Officer, Director
John McEleneyDirector
Executive officers, directors and promoters as listed on the Form D.